Non-small cell lung cancer
Conditions
Interventions
experimental group:Comprehensive treatment (adjuvant chemotherapy and treatment of TCM )
control group:Adjuvant chemotherapy and placebo
Sponsors
Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) patients with complete resection who are at TNM stage Ib-?a, postoperative pathology confirmed for non-small cell lung cancer; (2) patients who are within 6 weeks after complete resection have not been treated; (3) TCM syndrome differentiation is Qi deficiency syndrome, yin deficiency syndrome or Qi and Yin deficiency syndrome; (4) aged 18-75 years old (including 18, 75); (5) Eastern Cooperative OncologyGroup (ECOG) PS of two or less; (6) normal hematological function with total neutrophil count> 1.5 x 10^9/L, platelets count > 100 x 10^9/L , Lhemoglobin > 100 mg/dl and normal liver functionand kidney function; (7) patients compliance is good, and patients can understand the situation of this study and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) expected lifetime < 6 months; (2) there is no clear pathological diagnosis; (3) patients with intentional liver, kidney and hematopoietic diseases; (4) patients with pregnancy or lactation; (5) patients with hisory of serirous mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 2-year disease-free survival rate;Disease-free survival, DFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life;ECOG Performance Status;symptoms lists questionnaire of traditional Chinese medicine;Overall survival;CEA(Carcino Embryonie Antigen);CA125 (Carbohydrate Antigen 125);CYFRA21-1(cytokeratin fragment antiogen 21-1); | — |
Countries
China
Contacts
Public ContactLingshuang Liu
Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed